Key result
Advanced aging impairs diastolic relaxation in mice, driven by mitochondrial dysfunction and lipotoxicity.
Why the study?
Does biological aging induce mitochondrial dysfunction and structural remodeling leading to diastolic dysfunction in mice?
Does biological aging induce mitochondrial dysfunction and structural remodeling leading to diastolic dysfunction in mice?
Integrative multi-omics in a mouse model demonstrates that cardiac aging is fundamentally driven by severe mitochondrial dysfunction, metabolic inflexibility, and lipotoxic stress, which collectively culminate in diastolic heart failure.
Animal data implicate mitochondrial-lipotoxic pathways in age-related diastolic dysfunction; leaves open human HFpEF translation and targeted therapies.
Aging is a key driver of cardiac dysfunction, promoting structural remodeling, metabolic alterations, and loss of cellular resilience. In aged hearts, extracellular matrix remodeling and collagen accumulation reduce ventricular compliance, impairing both diastolic function and stress adaptability. Cardiomyocytes exhibit diminished regenerative capacity and dysregulated stress responses, with mitochondrial dysfunction emerging as a central contributor to energy imbalance, oxidative stress, and fibrosis. Traditional single-omics approaches are insufficient to capture the complexity of these interconnected changes. To address this, we employed an integrative multi-omics strategy-combining spatial transcriptomics, proteomics, and metabo-lipidomics with electron microscopy-to investigate cardiac aging in mice at three life stages: adult (12 months), middle-aged (24 months), and elderly (30 months). Electron microscopy revealed enlarged, structurally compromised mitochondria. Spatial transcriptomics showed reduced expression of cardioprotective genes (MANF, CISH, and BNP) and increased expression of profibrotic markers like CTGF. Proteomics revealed widespread mitochondrial dysregulation and impaired ATP production. Metabolic and lipidomic profiling identified reduced antioxidant metabolites and accumulation of lipotoxic species, such as ceramides and diacylglycerols. This multiscale analysis highlights key molecular and metabolic alterations driving cardiac aging, identifying potential therapeutic targets to mitigate age-related functional decline. Overall, our findings highlight the value of integrated, system-level approaches for uncovering the complex mechanisms that drive organ aging. Although our study was conducted in mice, validation in human models will be crucial to establish the translational relevance of these results and to guide future research with potential impact across diverse biomedical fields.
No takes yet. Share an insight, caveat, or question.
Basilicata et al. (2025) studied Cardiac aging and diastolic dysfunction. Aging (30 months of age) vs. Adult mice (12 months of age) was evaluated on E/A ratio (diastolic relaxation) (Hedges' g = -1.55, p=0.009-0.020). Elderly mice (30 months) exhibited marked impairment of diastolic relaxation compared to adult mice, driven by severe mitochondrial dysfunction, lipotoxicity, and fibrotic remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: